Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2004 Dec 20;14(24):6045-8.

Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.

Author information

1
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. daishi_su@merck.com

Abstract

We have developed an efficient and selective radioligand, the [35S]-radiolabeled dihydroquinoxalinone derivative, 4, for an ex vivo receptor occupancy assay in transgenic rats over-expressing the human bradykinin B1 receptor.

PMID:
15546726
DOI:
10.1016/j.bmcl.2004.09.074
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center